Drug
Aav2 Haadc
Aav2 Haadc: highest development phase Phase 2, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AAV2-hAADC NCT02926066 | Phase 2 | Aromatic Amino Acid Decarboxylase Deficiency |
Latest
No recent events.
Follow Aav2 Haadc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.